Indian Company Master Data Made Simple
Novelix Pharmaceuticals Limited
Novelix Pharmaceuticals Limited, established in 1994, boasts 31 years of expertise in its field. It is registered under CIN L67120TG1994PLC018956 and registration number 18956. It falls under the category of company limited by shares. Its authorized share capital is ₹20.00 crore. Novelix Pharmaceuticals Limited reports paid-up capital of ₹9.95 crore.
The firm focuses on activities auxiliary to financial intermediation. This entity is registered in Hyderabad, India. Its official registered office is situated at Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029. Novelix Pharmaceuticals Limited remains active and operational. The company’s official contact email is [email protected].
Profile data last updated: 15/12/2024
Company Overview
- CIN
- Date of Incorporation
- 13/12/1994
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2023
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹20,00,00,000.00
- Paid up Capital
- ₹9,95,00,000.00
- Activity
- Activities Auxiliary TO Financial Intermediation
- [email protected]
- PAN
Balance Sheet
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Total Non Current Liabilities Net Minority Interest | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Investment Properties | ₹0.00L | ₹0.00L | ₹0.00L | ₹173.88L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹966.71L | ₹1.01L | ₹6.16L | ₹0.82L | ₹0.00L |
| Tangible Book Value | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Long Term Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹13.08L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹0.00L | ₹0.00L | ₹0.00L | ₹3.37L | ₹0.00L |
| Total Assets | ₹2,720.64L | ₹736.49L | ₹725.68L | ₹725.12L | ₹0.00L |
| Machinery Furniture Equipment | ₹129.15L | ₹129.15L | ₹120.38L | ₹114.98L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Gross PPE | ₹143.46L | ₹143.46L | ₹134.69L | ₹134.25L | ₹0.00L |
| Total Capitalization | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Common Stock | ₹995.00L | ₹810.00L | ₹810.00L | ₹810.00L | ₹0.00L |
| Total Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹16.45L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Equity Interest | ₹758.93L | -₹74.52L | ₹0.00L | ₹6.98L | -₹123.54L |
| Other Non Current Liabilities | -₹0.01L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.01L |
| Capital Stock | ₹995.00L | ₹810.00L | ₹810.00L | ₹810.00L | ₹0.00L |
| Additional Paid In Capital | ₹946.50L | ₹121.50L | ₹121.50L | ₹121.50L | ₹0.00L |
| Total Non Current Assets | ₹27.35L | ₹323.51L | ₹301.40L | ₹261.91L | ₹0.00L |
| Invested Capital | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹770.17L | ₹261.78L | ₹277.47L | ₹260.49L | ₹0.00L |
| Net Tangible Assets | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Prepaid Assets | ₹711.50L | ₹0.08L | ₹1.30L | ₹0.28L | ₹0.00L |
| Cash And Cash Equivalents | ₹67.86L | ₹11.78L | ₹27.47L | ₹260.49L | ₹0.00L |
| Stockholders Equity | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Other Short Term Investments | ₹702.31L | ₹250.00L | ₹250.00L | ₹39.68L | ₹0.00L |
| Share Issued | ₹99.50L | ₹81.00L | ₹81.00L | ₹81.00L | ₹0.00L |
| Current Assets | ₹2,693.29L | ₹412.98L | ₹424.27L | ₹463.21L | ₹0.00L |
| Working Capital | ₹1,726.57L | ₹411.97L | ₹418.11L | ₹462.39L | ₹0.00L |
| Ordinary Shares Number | ₹99.50L | ₹81.00L | ₹81.00L | ₹81.00L | ₹0.00L |
| Current Debt | ₹0.00L | ₹0.00L | ₹0.00L | ₹3.37L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹0.00L | ₹0.00L | ₹0.00L | ₹13.08L | ₹0.00L |
| Current Liabilities | ₹966.72L | ₹1.01L | ₹6.16L | ₹0.82L | ₹0.00L |
| Net PPE | ₹18.57L | ₹22.37L | ₹17.42L | ₹22.60L | ₹0.00L |
| Construction In Progress | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Non Current Assets | -₹3.80L | -₹10.61L | ₹0.00L | ₹0.00L | ₹136.45L |
| Common Stock Equity | ₹1,753.93L | ₹735.48L | ₹719.51L | ₹724.31L | ₹0.00L |
| Other Intangible Assets | ₹0.00L | ₹0.00L | ₹0.00L | ₹1.06L | ₹0.00L |
| Inventory | ₹84.32L | ₹119.45L | ₹82.06L | ₹53.19L | ₹0.00L |
| Other Properties | ₹18.57L | ₹0.00L | ₹14.31L | ₹14.31L | ₹1.23L |
Cash Flow
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Changes In Cash | ₹66.09L | -₹15.70L | -₹233.02L | ₹86.81L | ₹0.00L |
| Financing Cash Flow | ₹1,131.50L | ₹0.00L | ₹0.00L | ₹0.00L | -₹76.72L |
| Free Cash Flow | -₹1,379.07L | -₹34.35L | -₹240.97L | -₹127.18L | ₹0.00L |
| Investing Cash Flow | ₹293.04L | ₹18.65L | ₹7.51L | ₹27.51L | ₹0.00L |
| End Cash Position | ₹67.87L | ₹11.79L | ₹27.47L | ₹260.49L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | -₹10.01L | ₹0.02L | ₹0.00L | -₹0.01L | ₹0.01L |
| Capital Expenditure | -₹10.61L | ₹0.00L | -₹0.44L | -₹186.48L | -₹2.95L |
| Beginning Cash Position | ₹11.79L | ₹27.47L | ₹260.49L | ₹173.68L | ₹0.00L |
| Operating Cash Flow | -₹1,358.45L | -₹34.35L | -₹240.53L | ₹59.30L | ₹0.00L |
| Issuance Of Capital Stock | ₹1,131.50L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Income Statement
| Metric | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
|---|---|---|---|---|---|
| Rent Expense Supplemental | ₹0.52L | ₹0.20L | ₹1.50L | ₹2.10L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Basic EPS | ₹0.00L | ₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| EBITDA | ₹16.13L | ₹6.04L | -₹51.77L | -₹51.76L | ₹0.00L |
| Total Expenses | ₹3,061.11L | ₹435.43L | ₹197.85L | ₹143.24L | ₹0.00L |
| Operating Revenue | ₹3,071.85L | ₹422.38L | ₹140.46L | ₹84.32L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | -₹2.68L | ₹7.28L | -₹0.45L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | -₹0.42L | -₹8.94L | ₹24.27L | -₹127.46L | ₹0.00L |
| Interest Income Non Operating | ₹1.60L | ₹20.44L | ₹27.27L | ₹29.78L | ₹0.00L |
| Interest Expense Non Operating | ₹0.00L | ₹0.10L | ₹0.00L | ₹5.77L | ₹5.40L |
| Net Income From Continuing And Discontinued Operation | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Reconciled Depreciation | ₹3.80L | ₹3.81L | ₹5.62L | ₹7.16L | ₹0.00L |
| Net Income Continuous Operations | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹2,957.37L | ₹383.63L | ₹135.22L | ₹80.82L | ₹0.00L |
| Net Income | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Operating Income | ₹11.23L | -₹13.05L | -₹57.39L | -₹58.92L | ₹0.00L |
| Diluted Average Shares | ₹99.41L | ₹104.12L | ₹81.00L | ₹81.00L | ₹0.00L |
| Normalized Income | ₹8.45L | ₹7.30L | -₹22.98L | -₹29.01L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹1.53L | ₹20.31L | ₹27.25L | ₹29.77L | ₹0.00L |
| Gross Profit | ₹114.48L | ₹38.75L | ₹5.24L | ₹3.50L | ₹0.00L |
| EBIT | ₹10.74L | ₹2.23L | -₹57.39L | -₹58.92L | ₹0.00L |
| Cost Of Revenue | ₹2,957.37L | ₹383.63L | ₹135.22L | ₹80.82L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Operating Expense | ₹103.74L | ₹51.80L | ₹62.63L | ₹62.42L | ₹0.00L |
| Normalized EBITDA | ₹14.54L | ₹14.98L | -₹76.04L | ₹75.70L | ₹0.00L |
| Net Income Common Stockholders | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Pretax Income | ₹12.33L | ₹2.13L | -₹5.85L | -₹156.58L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Revenue | ₹3,071.85L | ₹422.38L | ₹140.46L | ₹84.32L | ₹0.00L |
| Other Operating Expenses | ₹38.89L | ₹15.61L | ₹15.03L | ₹15.23L | ₹0.00L |
| Diluted EPS | ₹0.00L | ₹0.00L | -₹0.00L | -₹0.00L | ₹0.00L |
| Interest Expense | ₹0.00L | ₹0.10L | ₹0.00L | ₹5.77L | ₹5.40L |
| Basic Average Shares | ₹99.41L | ₹104.12L | ₹81.00L | ₹81.00L | ₹0.00L |
| Tax Provision | ₹3.88L | ₹1.08L | ₹0.15L | -₹0.55L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹8.45L | ₹1.04L | -₹5.99L | -₹156.03L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 01/04/2019 | Nishita Kalantri | *****2207C | Company Secretary | |
| 07/06/2022 | Monam Kapoor | 09278005 | Director | View other directorships |
| 02/09/2024 | Gnana Prakash Gattu | 00517921 | Additional Director | View other directorships |
| 02/09/2024 | Venkateshwarlu Pulluru | 02076871 | Additional Director | View other directorships |
| 02/09/2024 | Janardhan Das Kabra | 02386627 | Additional Director | View other directorships |
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 16/10/2024 | Resignation letter-16102024 | - |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dirc Investments Ltd. | L67120AS1985PLC002404 | 302 Frutos Tradecentre Srcb Road Guwahati Kamrup As 781001 In |
| Exel Capital Services Limited | L67120CH1989PLC009085 | # 1639near Fort Gate Manimajra, Chandigarh Ut, Chandigarh, India, 000000 |
| Inani Securities Limited | L67120AP1994PLC017583 | 5-8-352/15, Room No.15,ground Floor Chirag Ali Lane Raghavaratna Towers, Hyderabad, Andhra Pradesh, India, 000000 |
| Steel City Securities Limited | L67120AP1995PLC019521 | Steel City Heights, 50-81-18, Main Road, Seethammapeta, Dwarakanagar, Visakhapatnam, Visakhapatnam (urban), Andhra Pradesh, India, 530016 |
| Williamson Financial Services Limited | L67120AS1971PLC001358 | Export Promotion Industrial Park, Plot No 1, Amingaon, Kamrup, North Guwahati, Assam, India, 781031 |
Address
Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029
FAQ
What is the incorporation date of Novelix Pharmaceuticals Limited?
The incorporation date of Novelix Pharmaceuticals Limited is 13/12/1994.
Who are the current board members & directors of Novelix Pharmaceuticals Limited?
The current board member of Novelix Pharmaceuticals Limited are:
- Monam Kapoor
- Gnana Prakash Gattu
- Venkateshwarlu Pulluru
- Janardhan Das Kabra
What is the registered address of Novelix Pharmaceuticals Limited?
The registered address of Novelix Pharmaceuticals Limited is Flat # 610, 6th Floor, H.no.3-6-237/610, Lingapur La Builders ( Also Known As Amrutha Estate), Himayathnagar, Hyderabad, Himayathnagar, Telangana, India, 500029.
What is the Corporate Identification Number of Novelix Pharmaceuticals Limited?
The Corporate Identification Number of Novelix Pharmaceuticals Limited is L67120TG1994PLC018956.